Nu Skin Enterprises, Inc. NUS
Set alert
4.65 USD -0.04 -0.85%
At close · Oct 30
4.65 0.00 0.00%
After hours · Oct 30, 4:01 PM ET
4.63 Day range 4.80
4.53 52-week range 11.54
- YTD
- -51.66%
- 1 year
- -56.21%
- Open
- 4.71
- Prev close
- 4.69
- Mkt cap
- 226.35M
- Vol
- 351.49K
- Avg vol
- 526.88K
- EPS
- -4.51
- P/E
- 0.00
- Div yield
- 3.64%
More statistics
- Low
- 4.63
- High
- 4.80
- Forward P/E
- 6.47
- Beta
- 1.13
- Short ratio
- 1.83
- Inst. own
- 81.02%
- Dividend
- 0.24
- Ex-div date
- Nov 28, 2024
- Earnings
- Feb 12, 2025
- 50-d avg
- 6.96
- 200-d avg
- 9.95
- 1y target
- 6.92
5Y chart
Events in this range
- Nov 24, 2021Dividend: 0.38
- Nov 25, 2021Dividend: 0.38
- Feb 25, 2022Dividend: 0.385
- May 26, 2022Dividend: 0.385
- Aug 25, 2022Dividend: 0.385
- Nov 23, 2022Dividend: 0.385
- Dec 7, 2022Dividend: 0.385
- Feb 24, 2023Dividend: 0.39
- May 25, 2023Dividend: 0.39
- Aug 24, 2023Dividend: 0.39
- Nov 1, 2023Earnings: 0.56; estimate 0.64; surprise -12.5%
- Nov 22, 2023Dividend: 0.39
- Jan 5, 2024Rating: DA Davidson · Neutral → Neutral
- Feb 14, 2024Earnings: 0.37; estimate 0.29; surprise 27.59%
- Feb 23, 2024Dividend: 0.06
- May 8, 2024Earnings: 0.09; estimate 0.05; surprise 80%
- May 9, 2024Rating: DA Davidson · Neutral → Neutral
- May 31, 2024Dividend: 0.06
- Aug 8, 2024Earnings: 0.21; estimate 0.18; surprise 16.67%
- Aug 9, 2024Rating: Citigroup · Neutral → Neutral
- Aug 12, 2024Rating: DA Davidson · Neutral → Neutral
- Aug 30, 2024Dividend: 0.06
- Oct 22, 2024Rating: Citigroup · Neutral → Neutral
- Nov 7, 2024Earnings: 0.17; estimate 0.2; surprise -15%
- Nov 29, 2024Dividend: 0.06
- Dec 20, 2024Rating: DA Davidson · Neutral → Neutral
- Feb 12, 2025Earnings: —; estimate 0.21; surprise —%
- Feb 24, 2025Dividend: 0.06
- May 30, 2025Dividend: 0.06
- Aug 29, 2025Dividend: 0.06
- Nov 28, 2025Dividend: 0.06
- Feb 27, 2026Dividend: 0.06
- May 29, 2026Dividend: 0.06
- Aug 28, 2026Dividend: 0.06
Signals (83)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 26, 2026 | 6 days ago |
| SMA: Bullish | Oct 12, 2026 | 2 weeks ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| RSI: Oversold | Jun 29, 2026 | 4 months ago |
| RSI: Oversold | May 25, 2026 | 5 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
| SMA: Bearish | Dec 22, 2025 | 10 months ago |
| SMA: Bearish | Dec 22, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| MACD: Sell Signal | Oct 13, 2025 | 1 year ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
| RSI: Overbought | Aug 18, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| SMA: Bullish | May 5, 2025 | 1 year ago |
| MACD: Buy Signal | May 5, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 14, 2025 | 1 year ago |
| SMA: Bearish | Mar 31, 2025 | 1 year ago |
| SMA: Bearish | Mar 24, 2025 | 1 year ago |
| SMA: Bullish | Feb 10, 2025 | 1 year ago |
| SMA: Bearish | Jan 6, 2025 | 1 year ago |
| SMA: Bullish | Dec 30, 2024 | 1 year ago |
| SMA: Bearish | Dec 16, 2024 | 1 year ago |
| SMA: Bullish | Nov 11, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 4, 2024 | 1 year ago |
| MACD: Sell Signal | Sep 2, 2024 | 2 years ago |
| RSI: Oversold | Aug 26, 2024 | 2 years ago |
| RSI: Oversold | Jul 15, 2024 | 2 years ago |
| RSI: Oversold | Jun 24, 2024 | 2 years ago |
| SMA: Bearish | Jun 10, 2024 | 2 years ago |
| SMA: Bullish | May 6, 2024 | 2 years ago |
| SMA: Bearish | Apr 22, 2024 | 2 years ago |
| SMA: Bullish | Apr 15, 2024 | 2 years ago |
| RSI: Oversold | Apr 8, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 25, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 26, 2024 | 2 years ago |
| RSI: Oversold | Feb 12, 2024 | 2 years ago |
| SMA: Bearish | Jan 29, 2024 | 2 years ago |
| SMA: Bullish | Jan 22, 2024 | 2 years ago |
| SMA: Bearish | Jan 8, 2024 | 2 years ago |
| SMA: Bullish | Dec 11, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 27, 2023 | 2 years ago |
| RSI: Oversold | Jul 31, 2023 | 3 years ago |
| RSI: Oversold | Jul 10, 2023 | 3 years ago |
| SMA: Bearish | Apr 24, 2023 | 3 years ago |
| SMA: Bearish | Apr 24, 2023 | 3 years ago |
| SMA: Bullish | Apr 17, 2023 | 3 years ago |
| SMA: Bullish | Apr 3, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 13, 2023 | 3 years ago |
| SMA: Bearish | Mar 6, 2023 | 3 years ago |
| SMA: Bearish | Feb 20, 2023 | 3 years ago |
| SMA: Bullish | Dec 19, 2022 | 3 years ago |
| SMA: Bearish | Dec 5, 2022 | 3 years ago |
| SMA: Bullish | Nov 28, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 14, 2022 | 3 years ago |
| SMA: Bullish | Nov 7, 2022 | 3 years ago |
| SMA: Bearish | Oct 31, 2022 | 4 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| RSI: Oversold | Sep 26, 2022 | 4 years ago |
| MACD: Sell Signal | Aug 29, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| SMA: Bullish | Aug 8, 2022 | 4 years ago |
| MACD: Buy Signal | Aug 8, 2022 | 4 years ago |
| SMA: Bearish | Jun 27, 2022 | 4 years ago |
| SMA: Bullish | Jun 20, 2022 | 4 years ago |
| SMA: Bearish | Jun 6, 2022 | 4 years ago |
| SMA: Bullish | May 30, 2022 | 4 years ago |
| SMA: Bearish | Apr 18, 2022 | 4 years ago |
| SMA: Bullish | Mar 28, 2022 | 4 years ago |
| SMA: Bearish | Feb 21, 2022 | 4 years ago |
| SMA: Bullish | Feb 14, 2022 | 4 years ago |
| RSI: Overbought | Feb 14, 2022 | 4 years ago |
| SMA: Bearish | Feb 7, 2022 | 4 years ago |
Key statistics
- Market cap
- 334.56M
- Enterprise value
- 614.80M
- Trailing P/E
- 0.00
- Forward P/E
- 6.47
- PEG ratio
- 0.00
- Price / sales
- 0.19
- Price / book
- 0.47
- EPS (TTM)
- -2.09
- Beta
- 1.13
- Dividend yield
- 3.64%
- Payout ratio
- 917.65%
- Profit margin
- -5.81%
- Revenue (TTM)
- 1.78B
- Revenue growth
- -13.80%
- Free cash flow
- 131.05M
- Total cash
- 244.09M
- Total debt
- 530.80M
- Return on equity
- -13.50%
- Shares outstanding
- 49.71M
- Short % of float
- 4.67%
- 50-day average
- 6.96
- 200-day average
- 9.95
Analyst view
Consensus: hold
Hold
Price target (mean) 6.92 +48.7% upside
Now 4.65
- Target (low)
- 6.75
- Target (mean)
- 6.92
- Target (high)
- 7.00
Ratings (0m) 3 0 buy · 3 hold · 0 sell
- Strong buy0
- Buy0
- Hold3
- Sell0
- Strong sell0
Next earnings
Feb 12, 2025
Expected Feb 12, 2025. Consensus EPS estimate 0.24582.
Financials — quick view
NUS Revenue — quarterly 320.11M
NUS Net income — quarterly -249.80M
NUS EPS — quarterly -5.14
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 12, 2025 | Dec 1, 2024 | 0.21 | — | — | — |
| Nov 7, 2024 | Sep 1, 2024 | 0.20 | 0.17 | -0.03 | -15.00% |
| Aug 8, 2024 | Jun 1, 2024 | 0.18 | 0.21 | +0.03 | +16.67% |
| May 8, 2024 | Mar 1, 2024 | 0.05 | 0.09 | +0.04 | +80.00% |
| Feb 14, 2024 | Dec 1, 2023 | 0.29 | 0.37 | +0.08 | +27.59% |
| Nov 1, 2023 | Sep 1, 2023 | 0.64 | 0.56 | -0.08 | -12.50% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 20, 2024 | DA Davidson | main | Neutral | Neutral |
| Oct 22, 2024 | Citigroup | main | Neutral | Neutral |
| Aug 12, 2024 | DA Davidson | main | Neutral | Neutral |
| Aug 9, 2024 | Citigroup | main | Neutral | Neutral |
| May 9, 2024 | DA Davidson | main | Neutral | Neutral |
| Jan 5, 2024 | DA Davidson | main | Neutral | Neutral |
About Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Country
- United States
- Website
- nuskin.com
News
- Nu Skin Enterprises to Announce Third Quarter 2026 Financial Results
- Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
- Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
- STMicroelectronics-NUS Lab Strengthens Low-Power Edge AI Push
- STMicroelectronics and NUS launch Corporate Lab to power the future of Edge AI in Singapore
- Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2Q26
- Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y
- Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript
- Nu Skin Enterprises Q2 Earnings Call Highlights
- Nu Skin Enterprises (NUS) Matches Q2 Earnings Estimates
Your note
Sign in to keep a note on NUS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BATTLE EMMA S. | Director | Stock Award(Grant) | Jun 6, 2024 | 19,223 |
| CAMPBELL DANIEL W | Director | Stock Award(Grant) | Jun 6, 2024 | 117,030 |
| CLARK CHAYCE DAVID | General Counsel | Stock Award(Grant) | Feb 26, 2024 | 158,175 |
| LIPMAN ANDREW D | Director | Sale | May 27, 2024 | 23,225 |
| NATHANSON LAURA | Director | Stock Award(Grant) | Jun 6, 2024 | 21,630 |
| SHEN ZHEQING | Director | Stock Award(Grant) | Jun 6, 2024 | 33,195 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 10.27% | 5,104,656 | 34.35M | Sep 29, 2024 |
| Blackrock Inc. | 9.24% | 4,592,141 | 30.91M | Sep 29, 2024 |
| Shaw D.E. & Co., Inc. | 4.06% | 2,020,057 | 13.59M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 3.69% | 1,832,196 | 12.33M | Sep 29, 2024 |
| Millennium Management Llc | 2.61% | 1,296,590 | 8.73M | Sep 29, 2024 |
| State Street Corporation | 2.51% | 1,245,677 | 8.38M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Pacer Small Cap U.S. Cash Cows 100 ETF | 4.77% | 2,373,503 | 15.97M | Jul 30, 2024 |
| Vanguard Total Stock Market Index Fund | 3.28% | 1,631,724 | 10.98M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.69% | 1,335,112 | 8.99M | Oct 30, 2024 |
| Federated Hermes MDT Small Cap Core Fund | 2.35% | 1,166,788 | 7.85M | Jul 30, 2024 |
| Vanguard Extended Market Index Fund | 1.63% | 809,977 | 5.45M | Sep 29, 2024 |
| Schwab Strategic Tr-Schwab Fundamental U.S. Small Company Index ETF | 1.29% | 641,656 | 4.32M | Aug 30, 2024 |